In the HIT-CF project, coordinated by UMC Utrecht, researchers from 16 European countries worked closely together to find a solution for people with rare variants of cystic fibrosis.
How do we ensure pluripotent stem cells are safe to use in patients? JoaquÃn Montilla Rojo dove into this question and developed an animal-free model.